A short, 60 seconds read that summarises 4 handpicked articles that are worth reading about:
NICE recommends CDF use of dostarlimab
Global Blood Therapeutics’ treatment for patients with sickle cell disease approved in Europe
Institute of Cancer Research labels NICE reforms a missed opportunity